[go: up one dir, main page]

GR1008442B - Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης - Google Patents

Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης

Info

Publication number
GR1008442B
GR1008442B GR20140100033A GR20140100033A GR1008442B GR 1008442 B GR1008442 B GR 1008442B GR 20140100033 A GR20140100033 A GR 20140100033A GR 20140100033 A GR20140100033 A GR 20140100033A GR 1008442 B GR1008442 B GR 1008442B
Authority
GR
Greece
Prior art keywords
salt
pharmaceutical formulation
formulation containing
containing aripiprazole
aripiprazole
Prior art date
Application number
GR20140100033A
Other languages
English (en)
Inventor
Ευαγγελος Ανδρεα Καραβας
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20140100033A priority Critical patent/GR1008442B/el
Priority to PCT/EP2015/000046 priority patent/WO2015106963A1/en
Priority to EP15707269.5A priority patent/EP3094315B1/en
Priority to ES15707269T priority patent/ES2785398T3/es
Publication of GR1008442B publication Critical patent/GR1008442B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά σκεύασμα δισκίων άμεσης αποδέσμευσης περιέχον έναν άτυπο αντιψυχωσικό παράγοντα, όπως Αριπιπραζόλη ή κάποιο φαρμακευτικά αποδεκτό άλας αυτής, ως δραστική ουσία καθώς και δραστική ποσότητα ενός τουλάχιστον φαρμακευτικά αποδεκτού υδατοδιαλυτού και ενός τουλάχιστον μη υδατοδιαλυτού αραιωτικού μέσου. Επίσης, η εφεύρεση αφορά και τη μέθοδο παρασκευής του ως άνω σκευάσματος.
GR20140100033A 2014-01-16 2014-01-16 Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης GR1008442B (el)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GR20140100033A GR1008442B (el) 2014-01-16 2014-01-16 Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης
PCT/EP2015/000046 WO2015106963A1 (en) 2014-01-16 2015-01-14 Pharmaceutical composition comprising aripiprazole or salt thereof
EP15707269.5A EP3094315B1 (en) 2014-01-16 2015-01-14 Pharmaceutical composition comprising aripiprazole or salt thereof
ES15707269T ES2785398T3 (es) 2014-01-16 2015-01-14 Composición farmacéutica que comprende Aripiprazol o sal del mismo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20140100033A GR1008442B (el) 2014-01-16 2014-01-16 Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης

Publications (1)

Publication Number Publication Date
GR1008442B true GR1008442B (el) 2015-03-05

Family

ID=52596922

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20140100033A GR1008442B (el) 2014-01-16 2014-01-16 Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης

Country Status (4)

Country Link
EP (1) EP3094315B1 (el)
ES (1) ES2785398T3 (el)
GR (1) GR1008442B (el)
WO (1) WO2015106963A1 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016189504A1 (en) * 2015-05-28 2016-12-01 Leiutis Pharmaceuticals Pvt Ltd Non-lyophilized compositions of aripiprazole and methods of preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1542668T1 (sl) 2002-08-20 2009-08-31 Bristol Myers Squibb Co Aripiprazol sestavljena formulacija in postopek
WO2007035348A2 (en) 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
EP2036545A1 (en) * 2006-01-05 2009-03-18 Teva Pharmaceutical Industries Ltd. Aripiprazole tablets
TR200604349A2 (tr) 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
GR1008186B (el) * 2013-04-22 2014-05-08 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου

Also Published As

Publication number Publication date
EP3094315A1 (en) 2016-11-23
EP3094315B1 (en) 2020-02-19
WO2015106963A1 (en) 2015-07-23
ES2785398T3 (es) 2020-10-06

Similar Documents

Publication Publication Date Title
IL247062A0 (en) Heterocyclic compounds, their preparation and pharmaceutical preparations containing them
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
LT3674298T (lt) Pakeistieji indazolai, jų gavimo būdas, juos turinčios farmacinės kompozicijos ir jų panaudojimas vaistų gamybai
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
TW201613911A (en) Heterocyclic compounds and uses thereof
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
DK3639813T3 (da) Flydende formulering omfattende nikotin til aerosolindgivelse
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
EP3180118A4 (en) Systems and methods for synthesizing chemical products, including active pharmaceutical ingredients
IL247239A0 (en) Complexes of sirolimus and its derivatives, a process for their preparation and pharmaceutical preparations containing them
IL246655B (en) A medical preparation containing a pyridyl amino acetic acid compound
IL249308B (en) The history of quinoline, their preparation and pharmaceutical preparations containing them
PH12017500348B1 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors
GB201611175D0 (en) Liquid pharmaceutical composition of clonidine
IL272806B1 (en) The history of boronic acid, its preparation and pharmaceutical preparations containing it
IN2014CH00840A (el)
HUP1500618A2 (en) Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical composition containing them
PH12016502568B1 (en) Novel heterocyclic compound
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
MX2017007380A (es) Compuestos organicos.
GR1008186B (el) Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
GR1008442B (el) Φαρμακευτικο σκευασμα περιεχον αριπιπραζολη ή αλας αυτης
PL3270912T4 (pl) Kompozycje farmaceutyczne zawierające kompleksy taksan-cyklodekstryna, sposób wytwarzania i sposoby zastosowania
MX2016006742A (es) Composicion farmaceutica.

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20150421